Evidence map›Paper›PMID 29142964›Full record

ArticleKidney international reports2017

Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis.

Qian Zhang, Mae Thamer, Onkar Kshirsagar, Yi Zhang

Abstract read
In one paragraph

Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
  3. Article
  4. Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qian ZhangMedical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Mae ThamerMedical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Onkar KshirsagarMedical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Yi ZhangMedical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.

Funding

Impact of Recent Payment Reform on Dialysis Modality Choice among ESRD PatientsR03HS022931 · AHRQ · MEDICAL TECHNOLOGY AND PRACTICE PATTERNS · PI ZHANG, YI · 2014 to 2015
$99k
AHRQ HHS R03 HS022931
6 · The paper itself

Abstract

introductionThe End Stage Renal Disease (ESRD) Prospective Payment System (PPS), implemented by the Centers for Medicare and Medicaid Services in January 2011, encouraged use of peritoneal dialysis (PD) through various financial incentives. Our goal was to determine whether PPS effectively increased PD use in incident dialysis patients.

methodsOur study used the United States Renal Data System (USRDS) to identify 430,927 adult patients who initiated dialysis between 2009 and 2012. The interrupted time series method was used to evaluate the association Centers for Medicare and Medicaid Services of PPS with PD use at dialysis initiation. We further stratified by patient demographics, predialysis care, and facility chain and profit status.

resultsInterrupted time series analysis indicated PPS was associated with increased PD use in the 2-year period after PPS (change in slope = 0.04, DISCUSSION: Implementation of the Centers for Medicare and Medicaid Services ESRD payment reform was associated with an increased use of PD in the 2 years after PPS. Our findings highlight the role of financial incentives in changing practice patterns to increase use of a dialysis modality considered to be both more cost-effective and empowering to ESRD patients. However, even after PPS, rates of PD use remain low among the dialysis population in the USA.

Indexed as

end-stage renal diseaseinterrupted time seriesperitoneal dialysisprospective payment system

Identifiers

PMID29142964
PMCPMC5678611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.